@michaelrynne.bsky.social
We had an amazing day in Belfast for the CLL Ireland and CLL Support UK patient and care partner conference.
A big thanks to the clinical community, patient speakers, and all those who attended.
A big thanks to the clinical community, patient speakers, and all those who attended.
June 1, 2025 at 7:27 AM
We had an amazing day in Belfast for the CLL Ireland and CLL Support UK patient and care partner conference.
A big thanks to the clinical community, patient speakers, and all those who attended.
A big thanks to the clinical community, patient speakers, and all those who attended.
Reposted
A major paper @nature.com this week found a significant decline in dementia after an outdated Shingles vaccine.
I've reviewed the study and many other relevant ones here
erictopol.substack.com/p/the-shingl...
I've reviewed the study and many other relevant ones here
erictopol.substack.com/p/the-shingl...
The Shingles Vaccine and Reduction of Dementia
A compelling new study adds to the body of data supporting some protection provided by the vaccine
erictopol.substack.com
April 5, 2025 at 6:06 PM
A major paper @nature.com this week found a significant decline in dementia after an outdated Shingles vaccine.
I've reviewed the study and many other relevant ones here
erictopol.substack.com/p/the-shingl...
I've reviewed the study and many other relevant ones here
erictopol.substack.com/p/the-shingl...
Cancer in Ireland
2 years ago, this treatment Ibrutinib plus venetoclax for CLL blood cancer became available in the UK.
It's now available in over 80 countries but not in Ireland.
Our drug approval system is failing patients.
www.onclive.com/view/fixed-d...
2 years ago, this treatment Ibrutinib plus venetoclax for CLL blood cancer became available in the UK.
It's now available in over 80 countries but not in Ireland.
Our drug approval system is failing patients.
www.onclive.com/view/fixed-d...
Fixed-Duration Ibrutinib/Venetoclax Elicits Meaningful Survival Benefit in High-Risk CLL/SLL
Fixed-duration ibrutinib plus venetoclax generated meaningful survival benefits and durable responses in high-risk subgroups of patients with CLL/SLL.
www.onclive.com
March 30, 2025 at 10:36 PM
Cancer in Ireland
2 years ago, this treatment Ibrutinib plus venetoclax for CLL blood cancer became available in the UK.
It's now available in over 80 countries but not in Ireland.
Our drug approval system is failing patients.
www.onclive.com/view/fixed-d...
2 years ago, this treatment Ibrutinib plus venetoclax for CLL blood cancer became available in the UK.
It's now available in over 80 countries but not in Ireland.
Our drug approval system is failing patients.
www.onclive.com/view/fixed-d...